From a universal flu vaccine that could save us from a pandemic, to vaccines that target ticks and mosquitoes, Horizon looks at the science of vaccines during the month of February.
The bacteria that causes TB infects over a quarter of the world’s population, and we speak to the European scientists who are closing in on a vaccine for the disease that could save millions of lives.
We also look at the rise of measles and mumps as a result of fears over the MMR vaccination – and interview researchers who are collecting information to try to prevent unnecessary future vaccine scares.
The days when measles was a killer disease affecting thousands are firmly in the past thanks to mass immunisations. However, a fall in vaccination rates means the disease is starting to make an unwelcome comeback in Europe – and European scientists have found a way to help.
The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
Researchers are studying the evolutionary changes in human jaws to better understand the forces at play, and their work could help improve dental treatment and even regrow lost teeth.
High-tech turf that combines real grass with synthetic microfibers and cork is helping reduce injuries and keep pitches playable during the heavy rainfall that has marked the European Championships in France this month.
People don’t know that hydrogen-fuelled vehicles and home heating systems are already on the market, and that is the biggest obstacle to their uptake, according to Bart Biebuyck, the recently appointed executive director of the Fuel Cells and Hydrogen Joint Undertaking, a public-private partnership between the EU and the fuel cell and hydrogen industries.
Hypersonic jets could go eight times the speed of sound.
Hydrogen will play a bigger role in Europe's transport and energy sectors but we have to let people know the tech is ready, says Bart Biebuyck.